[Current therapy of multiple sclerosis: are there indications for intravenous immunoglobulins?]
Nervenarzt
.
1995 Apr;66(4):304-7.
[Article in German]
Authors
S Schmidt
1
,
R Hohlfeld
Affiliation
1
Max-Planck-Institut für Psychiatrie, Abteilung Neuroimmunologie, Martinsried, München.
PMID:
7783819
No abstract available
Publication types
Review
MeSH terms
Clinical Trials as Topic
Humans
Immunization, Passive* / adverse effects
Multiple Sclerosis / etiology
Multiple Sclerosis / therapy*
Treatment Outcome